News
Posted: September 11, 2018 | News, Press
AMSure® Pre-filled Syringe for Balloon Inflation Receives FDA 510(k) Clearance
Pomona, Ca — Amsino Medical Group announces that the new AMSure® pre-filled syringe for balloon inflation with sterile water has received United States Food and Drug Administration (FDA) 510(k) clearance as a Urological Catheter and Accessories, Class II device for indwelling catheter balloon inflation applications. Amsino has expanded its manufacturing capabilities to include the production of sterile saline water products. This new clearance is a first in a series of advancements and sterile water product line extensions at Amsino.
Posted: September 11, 2018 |
AMSure® Sterile Water and Sterile Normal Saline for Wound Flush Receives FDA 510(k) Clearance
Pomona, Ca — Amsino Medical Group announces that the AMSure sterile water and sterile normal saline for wound flush has received United States Food and Drug Administration (FDA) 510(k) clearance as an unclassified pre-amendment device for both over-the-counter and prescription use, marking the expansion of Amsino manufactured saline and sterile water products in the industry.
Posted: September 10, 2018 |
Amsino’s Sure-Lok® Needle-free Connector Receives FDA 510(k) Clearance
Pomona, Ca — Amsino Medical Group Ltd. is pleased to announce that its new Sure-Lok needle-free connector has received United States Food and Drug Administration (FDA) 510(k) clearance as an Intravascular Administration Set, Class II device for I.V. administration applications. This new clearance allows Amsino to increase its product reach, further deepening the company’s overall I.V. medication delivery global platform.
Posted: September 3, 2018 | Press
Amsino is Poised for Further Growth with the Acquisition of Shanghai Regent Medical Technology Company and its iRECEPTAL™ Waste Fluid Management System
Shanghai, China — Amsino Medical Group is delighted to announce the closing of an acquisition of Shanghai Regent Medical Technology Co., Ltd., a Shanghai based medical technology firm that has successfully developed an innovative waste fluid management system. The system, now under the trade name of “iRECEPTAL”, is the first of its kind in today’s Chinese market with the ability to provide a closed waste fluid management system that reduces/minimizes the chance of infection and that specifically addresses the unique clinical needs of large volume liquid surgical procedures. This acquisition positions Amsino as a forerunner in this market.
Posted: October 26, 2015 | News
Mayor meets Committee of 100 Leadership representatives
Shanghai Mayor Yang Xiong met representatives from Committee of 100, including Mr. Richard Lee, Chairman and CEO of Amsino Medical Group, on October 20, 2015.
Mayor Yang thanked Committee of 100 LSP for their contribution to Shanghai’s economic and social development, and encouraged them to seize the opportunity of Shanghai’s development expand their own businesses and actively participate in the future growth of Shanghai. He said the municipal government will continue to support them in developing businesses in the city. He hoped Committee of 100 can play a bigger role in Shanghai’s development.